Giulia Pasello

InstitutionUniversity of Padova
AddressItaly
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 2 Covid-19 publications, with a maximum of 1 publications in June 2020 and June 2021
    All Publications
    Bar chart showing 42 publications over 14 distinct years, with a maximum of 6 publications in 2015 and 2017 and 2019
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pasello G, Menis J, Pilotto S, Frega S, Belluomini L, Pezzuto F, Caliò A, Sepulcri M, Cernusco NLV, Schiavon M, Infante MV, Damin M, Micheletto C, Del Bianco P, Giovannetti R, Bonanno L, Fantoni U, Guarneri V, Calabrese F, Rea F, Milella M, Conte P. How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center. Front Oncol. 2021; 11:669786. PMID: 34262861.
      Citations: 2     
    2. Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, Baena J, Banna G, Berardi R, Bettini AC, Bria E, Brighenti M, Cadranel J, De Toma A, Chini C, Cortellini A, Felip E, Finocchiaro G, Garrido P, Genova C, Giusti R, Gregorc V, Grossi F, Grosso F, Intagliata S, La Verde N, Liu SV, Mazieres J, Mercadante E, Michielin O, Minuti G, Moro-Sibilot D, Pasello G, Passaro A, Scotti V, Solli P, Stroppa E, Tiseo M, Viscardi G, Voltolini L, Wu YL, Zai S, Pancaldi V, Dingemans AM, Van Meerbeeck J, Barlesi F, Wakelee H, Peters S, Horn L. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020 07; 21(7):914-922. PMID: 32539942.
      Citations: 189     Fields:    Translation:HumansCellsPHPublic Health
    3. Frega S, Dal Maso A, Ferro A, Bonanno L, Conte PF, Pasello G. Corrigendum to "Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?" [Crit. Rev. Oncol. Hematol. 138 (June) (2019), 87-103]. Crit Rev Oncol Hematol. 2019 Aug; 140:73. PMID: 31176852.
      Citations:    Fields:    
    4. Comacchio GM, Schiavon M, Azzolina D, Mammana M, Marulli G, Zuin A, Verderi E, Monaci N, Bonanno L, Pasello G, Rea F. Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections? World J Surg. 2019 May; 43(5):1385-1392. PMID: 30659342.
      Citations: 1     Fields:    Translation:Humans
    5. Bonanno L, Pavan A, Pasello G, Indraccolo S. Editorial on "The AvaALL Randomized Clinical Trial". J Thorac Dis. 2019 May; 11(Suppl 9):S1237-S1240. PMID: 31245096.
      Citations: 1     
    6. Bonanno L, Zulato E, Pavan A, Attili I, Pasello G, Conte P, Indraccolo S. LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer. Int J Mol Sci. 2019 Apr 16; 20(8). PMID: 30995715.
      Citations: 14     Fields:    Translation:HumansAnimals
    7. Frega S, Dal Maso A, Ferro A, Bonanno L, Conte P, Pasello G. Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter? Crit Rev Oncol Hematol. 2019 Jun; 138:87-103. PMID: 31092389.
      Citations: 4     Fields:    Translation:Humans
    8. Bonanno L, Pavan A, Attili I, Pasello G, Guarneri V. Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy. J Thorac Oncol. 2019 01; 14(1):e5-e7. PMID: 30579553.
      Citations: 3     Fields:    Translation:Humans
    9. Imbimbo M, Ottaviano M, Vitali M, Fabbri A, Leuzzi G, Fiore M, Franceschini D, Pasello G, Perrino M, Schiavon M, Pruneri G, Dei Tos AP, Sangalli C, Garassino MC, Berardi R, Alessi A, Calareso G, Petrini I, Scorsetti M, Scotti V, Rosso L, Rea F, Pastorino U, Casali PG, Ramella S, Ricardi U, Abate-Daga L, Torri V, Trama A, Palmieri G, Marino M, Zucali PA. Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). Cancer Treat Rev. 2018 Dec; 71:76-87. PMID: 30366202.
      Citations: 12     Fields:    Translation:Humans
    10. Pelosi G, Papotti M, Righi L, Rossi G, Ferrero S, Bosari S, Calabrese F, Kern I, Maisonneuve P, Sonzogni A, Albini A, Harari S, Barbieri F, Capelletto E, Catino AM, Cavone D, De Palma A, Fusco N, Lunardi F, Maiorano E, Marzullo A, Novello S, Papanikolaou N, Pasello G, Pennella A, Pezzuto F, Punzi A, Prisciandaro E, Rea F, Rosso L, Scattone A, Serio G. Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal. J Thorac Oncol. 2018 11; 13(11):1750-1761. PMID: 30249391.
      Citations: 9     Fields:    Translation:Humans
    11. Imbimbo M, Vitali M, Fabbri A, Ottaviano M, Pasello G, Petrini I, Palmieri G, Berardi R, Zucali P, Ganzinelli M, Marabese M, Broggini M, Marino M, Trama A, Rulli E, Hollander L, Pruneri G, Torri V, Garassino MC. RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma. Clin Lung Cancer. 2018 09; 19(5):e811-e814. PMID: 30033090.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    12. Frega S, Bonanno L, Guarneri V, Conte P, Pasello G. Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future? Crit Rev Oncol Hematol. 2018 Aug; 128:19-29. PMID: 29958628.
      Citations: 5     Fields:    Translation:Humans
    13. Zucali PA, De Pas T, Palmieri G, Favaretto A, Chella A, Tiseo M, Caruso M, Simonelli M, Perrino M, De Vincenzo F, Toffalorio F, Damiano V, Pasello G, Garbella E, Ali M, Conforti F, Ottaviano M, Cioffi A, De Placido S, Giordano L, Bertossi M, Destro A, Di Tommaso L, Santoro A. Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy. J Clin Oncol. 2018 02 01; 36(4):342-349. PMID: 29240542.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    14. Gobbini E, Pilotto S, Pasello G, Polo V, Di Maio M, Arizio F, Galetta D, Petrillo P, Chiari R, Matocci R, Di Costanzo A, Di Stefano TS, Aglietta M, Cagnazzo C, Sperduti I, Bria E, Novello S. Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. Clin Lung Cancer. 2018 03; 19(2):191-198. PMID: 29153968.
      Citations: 1     Fields:    Translation:Humans
    15. Urso L, Cavallari I, Silic-Benussi M, Biasini L, Zago G, Calabrese F, Conte PF, Ciminale V, Pasello G. Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists. Oncotarget. 2017 Jul 04; 8(27):44232-44241. PMID: 28562336.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    16. Frega S, Lorenzi M, Fassan M, Indraccolo S, Calabrese F, Favaretto A, Bonanno L, Polo V, Zago G, Lunardi F, Attili I, Pavan A, Rugge M, Guarneri V, Conte P, Pasello G. Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations. Oncotarget. 2017 May 16; 8(20):32626-32638. PMID: 28427238.
      Citations: 4     Fields:    Translation:Humans
    17. Mencoboni M, Filiberti RA, Taveggia P, Grosso F, Pasello G, Del Corso L, Muzio A, Polo V, Zucali P, Ceresoli GL, Soto Parra HJ, Auriati L, Simonassi C. Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma. Oncol Res Treat. 2017; 40(6):364-369. PMID: 28472807.
      Citations:    Fields:    Translation:Humans
    18. Russo I, Sacco G, Frega S, Polo V, Pasello G, Alaibac M. Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumab. Eur J Dermatol. 2017 04 01; 27(2):205-208. PMID: 28251900.
      Citations: 4     Fields:    Translation:Humans
    19. Bonanno L, Zago G, Marulli G, Del Bianco P, Schiavon M, Pasello G, Polo V, Canova F, Tonetto F, Loreggian L, Rea F, Conte P, Favaretto A. Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment. Onco Targets Ther. 2016; 9:3671-81. PMID: 27382305.
      Citations:    
    20. Polo V, Pasello G, Frega S, Favaretto A, Koussis H, Conte P, Bonanno L. Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization. Oncotarget. 2016 May 03; 7(18):25050-63. PMID: 26933818.
      Citations: 2     Fields:    Translation:Humans
    21. Frega S, Conte P, Fassan M, Polo V, Pasello G. A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib. J Thorac Oncol. 2016 05; 11(5):e63-e64. PMID: 27131295.
      Citations: 5     Fields:    Translation:Humans
    22. Pasello G, Urso L, Mencoboni M, Grosso F, Ceresoli GL, Lunardi F, Vuljan SE, Bertorelle R, Sacchetto V, Ciminale V, Rea F, Favaretto A, Conte P, Calabrese F. MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data. Oncotarget. 2015 Dec 08; 6(39):42053-66. PMID: 26544728.
      Citations: 7     Fields:    Translation:Humans
    23. Ferrazzi A, Russo I, Pasello G, Alaibac M. Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature. Exp Ther Med. 2016 Jan; 11(1):197-200. PMID: 26889239.
      Citations: 4     
    24. Polo V, Zago G, Frega S, Canova F, Bonanno L, Favaretto A, Bonaldi L, Bertorelle R, Conte P, Pasello G. Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature. Am J Case Rep. 2015 Nov 03; 16:782-9. PMID: 26525068.
      Citations: 4     Fields:    Translation:Humans
    25. Urso L, Calabrese F, Favaretto A, Conte P, Pasello G. Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment. Crit Rev Oncol Hematol. 2016 Jan; 97:220-30. PMID: 26358421.
      Citations: 16     Fields:    Translation:HumansAnimals
    26. Pasello G, Carli P, Canova F, Bonanno L, Polo V, Zago G, Urso L, Conte P, Favaretto A. Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancer. Anticancer Res. 2015 Apr; 35(4):2183-9. PMID: 25862876.
      Citations: 1     Fields:    Translation:Humans
    27. Marulli G, Battistella L, Perissinotto E, Breda C, Favaretto AG, Pasello G, Zuin A, Loreggian L, Schiavon M, Rea F. Results of surgical resection after induction chemoradiation for Pancoast tumours †. Interact Cardiovasc Thorac Surg. 2015 Jun; 20(6):805-11; discussion 811-2. PMID: 25757477.
      Citations: 4     Fields:    Translation:Humans
    28. Schiavon M, Marulli G, Nannini N, Pasello G, Lunardi F, Balestro E, Perissinotto E, Rebusso A, Saetta M, Rea F, Calabrese F. COPD-related adenocarcinoma presents low aggressiveness morphological and molecular features compared to smoker tumours. Lung Cancer. 2014 Dec; 86(3):311-7. PMID: 25454198.
      Citations: 7     Fields:    Translation:HumansCells
    29. Marulli G, Verderi E, Zuin A, Schiavon M, Battistella L, Perissinotto E, Romanello P, Favaretto AG, Pasello G, Rea F. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection. Interact Cardiovasc Thorac Surg. 2014 Aug; 19(2):256-62; discussion 262. PMID: 24824495.
      Citations: 8     Fields:    Translation:Humans
    30. Pasello G, Urso L, Conte P, Favaretto A. Effects of sulfonylureas on tumor growth: a review of the literature. Oncologist. 2013; 18(10):1118-25. PMID: 24043597.
      Citations: 17     Fields:    Translation:Humans
    31. Marulli G, Di Chiara F, Braccioni F, Perissinotto E, Pasello G, Favaretto AG, Breda C, Rea F. Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2013 Jul; 44(1):104-10. PMID: 23349323.
      Citations: 1     Fields:    Translation:Humans
    32. Pasello G, Marulli G, Polo V, Breda C, Bonanno L, Loreggian L, Rea F, Favaretto A. Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM). Anticancer Res. 2012 Dec; 32(12):5393-9. PMID: 23225442.
      Citations: 1     Fields:    Translation:Humans
    33. Rumiato E, Pasello G, Montagna M, Scaini MC, De Salvo GL, Parenti A, Cagol M, Ruol A, Ancona E, Amadori A, Saggioro D. DNA copy number profile discriminates between esophageal adenocarcinoma and squamous cell carcinoma and represents an independent prognostic parameter in esophageal adenocarcinoma. Cancer Lett. 2011 Nov 01; 310(1):84-93. PMID: 21757289.
      Citations: 9     Fields:    Translation:Humans
    34. Pasello G, Nicotra S, Marulli G, Rea F, Bonanno L, Carli P, Magro C, Jirillo A, Favaretto A. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience. Lung Cancer. 2011 Sep; 73(3):351-5. PMID: 21296448.
      Citations: 3     Fields:    Translation:Humans
    35. Bonanno L, Schiavon M, Nardo G, Bertorelle R, Bonaldi L, Galligioni A, Indraccolo S, Pasello G, Rea F, Favaretto A. Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma. Anticancer Res. 2010 Dec; 30(12):5121-8. PMID: 21187500.
      Citations: 20     Fields:    Translation:Humans
    36. Pasello G, Altavilla G, Bonanno L, Rea F, Favaretto AG. A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report. J Thorac Dis. 2010 Dec; 2(4):254. PMID: 22263055.
      Citations: 1     
    37. Sidi R, Pasello G, Opitz I, Soltermann A, Tutic M, Rehrauer H, Weder W, Stahel RA, Felley-Bosco E. Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. Eur J Cancer. 2011 Jan; 47(2):326-32. PMID: 21036600.
      Citations: 24     Fields:    Translation:Humans
    38. Favaretto AG, Pasello G, Magro C. Second and third line treatment in advanced non-small cell lung cancer. Discov Med. 2009 Dec; 8(43):204-9. PMID: 20040271.
      Citations: 5     Fields:    Translation:Humans
    39. Pasello G, Favaretto A. Molecular targets in malignant pleural mesothelioma treatment. Curr Drug Targets. 2009 Dec; 10(12):1235-44. PMID: 19909234.
      Citations: 10     Fields:    Translation:HumansAnimals
    40. Favaretto A, Pasello G, Loreggian L, Breda C, Braccioni F, Marulli G, Stragliotto S, Magro C, Sotti G, Rea F. Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: A mono-institutional experience. Lung Cancer. 2010 May; 68(2):228-33. PMID: 19632000.
      Citations: 3     Fields:    Translation:Humans
    41. Favaretto A, Pasello G, Magro C, Schettino C, Gridelli C. Second and third line treatment in non-small cell lung cancer. Crit Rev Oncol Hematol. 2009 Aug; 71(2):117-26. PMID: 19249227.
      Citations: 4     Fields:    Translation:Humans
    42. Pasello G, Agata S, Bonaldi L, Corradin A, Montagna M, Zamarchi R, Parenti A, Cagol M, Zaninotto G, Ruol A, Ancona E, Amadori A, Saggioro D. DNA copy number alterations correlate with survival of esophageal adenocarcinoma patients. Mod Pathol. 2009 Jan; 22(1):58-65. PMID: 18820669.
      Citations: 11     Fields:    Translation:Humans